Molecular diagnosis of necrotizing fasciitis by 16S rRNA gene sequencing and superantigen gene detection

Journal of Molecular Diagnostics

Volumn 7, Issue 5, 2005, Pages 641-645

  Muldrew, Kenneth L ^a   Simpson, Jean F ^a   Stratton, Charles W ^a   Tang, Yi Wei ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CEFAZOLIN; CLINDAMYCIN; EOSIN; GENTAMICIN; HEMATOXYLIN; HYPERTENSIVE FACTOR; INFUSION FLUID; PARAFFIN; RNA 16S; SUPERANTIGEN; VANCOMYCIN;

ADULT; ARTICLE; AUTOPSY; BACTERIAL GENE; BETA HEMOLYTIC STREPTOCOCCUS; BLEEDING; CLINICAL ARTICLE; DEATH; EDEMA; ELECTROENCEPHALOGRAM; ERYTHEMA; FEMALE; FLUSHING; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC IDENTIFICATION; GRAM POSITIVE BACTERIUM; GRAM STAINING; HEART VENTRICLE FIBRILLATION; HOSPITAL ADMISSION; HUMAN; MULTIPLE ORGAN FAILURE; NECROTIZING FASCIITIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RESUSCITATION; STREPTOCOCCUS PYOGENES; TISSUE CULTURE;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STREPTOCOCCUS; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP A';

EID: 27744524860     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-1578(10)60599-5     Document Type: Article

References (30)

1. Brown RC, Hopps HC: Staining of bacteria in tissue sections: a reliable gram stain method. Am J Clin Pathol 1973, 60:234-240
2. Khulordava I, Miller G, Haas D, Li H, McKinsey J, Vanderende D, Tang YW: Identification of the bacterial etiology of culture-negative endocarditis by amplification and sequencing of a small ribosomal RNA gene. Diagn Microbiol Infect Dis 2003, 46:9-11
3. Tang YW, Von Graevenitz A, Waddington MG, Hopkins MK, Smith DH, Li H, Kolbert CP, Montgomery SO, Persing DH: Identification of coryneform bacterial isolates by ribosomal DNA sequence analysis. J Clin Microbiol 2000, 38:1676-1678
4. Black CM, Talkington DF, Messmer TO, Facklam RR, Hornes E, Olsvik O: Detection of streptococcal pyrogenic exotoxin genes by a nested polymerase chain reaction. Mol Cell Probes 1993, 7:255-259
5. Li H, Dummer JS, Estes WR, Meng S, Wright PF, Tang YW: Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients. J Clin Microbiol 2003, 41:187-191
6. Weeks CR, Ferretti JJ: Nucleotide sequence of the type A streptococcal exotoxin (erythrogenic toxin) gene from Streptococcus pyogenes bacteriophage T12. Infect Immun 1986, 52:144-150
7. Smoot JC, Barbian KD, Van Gompel JJ, Smoot LM, Chaussee MS, Sylva GL, Sturdevant DE, Ricklefs SM, Porcella SF, Parkins LD, Beres SB, Campbell DS, Smith TM, Zhang Q, Kapur V, Daly JA, Veasy LG, Musser JM: Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc Natl Acad Sci USA 2002, 99:4668-4673
8. Beall B, Facklam R, Thompson T: Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 1996, 34:953-958
9. Ferretti JJ, McShan WM, Ajdic D, Savic DJ, Savic G, Lyon K, Primeaux C, Sezate S, Suvorov AN, Kenton S, Lai HS, Lin SP, Qian Y, Jia HG, Najar FZ, Ren Q, Zhu H, Song L, White J, Yuan X, Clifton SW, Roe BA, McLaughlin R: Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc Natl Acad Sci USA 2001, 98:4658-4663
10. Chelsom J, Halstensen A, Haga T, Hoiby EA: Necrotizing fasciitis due to group A streptococci in western Norway: incidence and clinical features. Lancet 1994, 344:1111-1115
11. McHenry CR, Piotrowski JJ, Petrinic D, Malangoni MA: Determinants of mortality for necrotizing soft-tissue infections. Ann Surg 1995, 221:558-565
12. Green RJ, Dafoe DC, Raffin TA: Necrotizing fasciitis. Chest 1996, 110:219-229
13. Hidalgo-Grass C, Dan-Goor M, Maly A, Eran Y, Kwinn LA, Nizet V, Ravins M, Jaffe J, Peyser A, Moses AE, Hanski E: Effect of bacterial pheromone peptide on host chemokine degradation in group A streptococcal necrotising soft-tissue infections. Lancet 2004, 363:696-703
14. Norrby-Teglund A, Thulin P, Gan BS, Kotb M, McGeer A, Andersson J, Low DE: Evidence for super-antigen involvement in severe group A streptococcal tissue infections. J Infect Dis 2001, 184:853-860
15. O'Brien KL, Beall B, Barrett NL, Cieslak PR, Reingold A, Farley MM, Danila R, Zell ER, Facklam R, Schwartz B, Schuchat A: Epidemiology of invasive group A streptococcus disease in the United States, 1995-1999. Clin Infect Dis 2002, 35:268-276
16. Stevens DL: Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis 1995, 1:69-78
17. Stevens DL: Invasive group A streptococcus infections. Clin Infect Dis 1992, 14:2-13
18. Schwartz B, Facklam RR, Breiman RF: Changing epidemiology of group A streptococcal infection in the USA. Lancet 1990, 336:1167-1171
19. Johnson DR, Stevens DL, Kaplan EL: Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis 1992, 166:374-382
20. Akesson P, Rasmussen M, Mascini E, von Pawel-Rammingen U, Janulczyk R, Collin M, Olsen A, Mattsson E, Olsson ML, Bjorck L, Christensson B: Low antibody levels against cell wall-attached proteins of Streptococcus pyogenes predispose for severe invasive disease. J Infect Dis 2004, 189:797-804
21. Mascini EM, Jansze M, Schellekens JFP, Musser JM, Faber JAJ, Verhoef-Verhage LAE, Schouls L, van Leeuwen WJ, Verhoef J, van Dijk H: Invasive group A streptococcal disease in The Netherlands: evidence for a protective role of anti-exotoxin A antibodies. J Infect Dis 2000, 181:631-638
22. Norrby-Teglund A, Kaul R, Low DE, McGeer A, Andersson J, Andersson U, Kotb M: Evidence for the presence of streptococcal-superantigen-neutralizing antibodies in normal polyspecific immunoglobulin G. Infect Immun 1996, 64:5395-5398
23. Unnikrishnan M, Altmann DM, Proft T, Wahid F, Cohen J, Fraser JD, Sriskandan S: The bacterial superantigen streptococcal mitogenic exotoxin Z is the major immunoactive agent of Streptococcus pyogenes. J Immunol 2002, 169:2561-2569
24. Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO: Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am 2003, 8:1454-1460
25. Fink S, Chaudhuri TK, Davis HH: Necrotizing fasciitis and malpractice claims. South Med J 1999, 92:770-774
26. Lille ST, Sato TT, Engrav LH, Foy H, Jurkovich GJ: Necrotizing soft tissue infections: obstacles in diagnosis. J Am Coll Surg 1996, 182:7-11
27. Zimbelman J, Palmer A, Todd J: Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J 1999, 18:1096-1100
28. Norrby-Teglund A, Norrby SR, Low DE: The treatment of severe group A streptococcal infections. Curr Infect Dis Rep 2003, 5:28-37
29. Malak K, Norrby-Teglund A, McGeer A, El-Sherbini H, Dorak MT, Khurshid A, Green K, Peeples J, Wade J, Thomson G, Schwartz B, Low DE: An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med 2002, 8:1398-1404
30. Jobbagy Z, Fabian CB, Memoli VA, Schwartzman JD: A novel Streptococcus organism identified in a case of fulminant endocarditis using 16S rDNA sequencing. J Mol Diagn 2004, 6:145-148